Aspirin

Product NDC: 50844-600
11-digit product format: 508440600
Labeler code: 50844
Product ID: 50844-600_62d04705-d057-45a8-b5c3-18c9c82caa65
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Labeler: L.N.K. International, Inc.
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2011-05-01
Substance: ASPIRIN
Active strength: 81 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	50844-600	50844-600-01	D	Discontinued by firm		2026-10-15
excluded package	package	50844-600	50844-600-17	D	Discontinued by firm		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	50844-600-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	50844-600-17	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	50844-600-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	50844-600-17	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	50844-600-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	50844-600-17	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	50844-600-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	50844-600-17	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	50844-600-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	50844-600-17	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	50844-600-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	50844-600-17	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	50844-600-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	50844-600-17	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	50844-600-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	50844-600-17	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	50844-600-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	50844-600-17	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	50844-600-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	50844-600-17	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	50844-600-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	50844-600-17	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	50844-600-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	50844-600-17	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Aspirin
Brand name suffix: Low Dose
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	81 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308416	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2f6ec676-3832-420e-be91-fce83f6586c8	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50844-600-01	AspirinLow Dose	1 in 1 BOX	TABLET, DELAYED RELEASE	1	17
50844-600-01	AspirinLow Dose	30 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	30	17
50844-600-14	AspirinLow Dose	500 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	500	17
50844-600-17	AspirinLow Dose	300 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	300	17
50844-600-17	AspirinLow Dose	1 in 1 BOX	TABLET, DELAYED RELEASE	1	17
50844-600-32	AspirinLow Dose	1 in 1 BOX	TABLET, DELAYED RELEASE	1	17
50844-600-32	AspirinLow Dose	120 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	120	17
50844-600-95	AspirinLow Dose	300 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	300	17

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
SODIUM BICARBONATE	INACTIVE INGREDIENT	8MDF5V39QO	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L.N.K. INTERNATIONAL, INC.]	5
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
METHACRYLIC ACID	INACTIVE INGREDIENT	1CS02G8656	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
SODIUM BICARBONATE	INACTIVE INGREDIENT	8MDF5V39QO	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	ADULT LOW DOSE ENTERIC COATED ASPIRIN (ASPIRIN) TABLET, COATED [TYA PHARMACEUTICALS]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50844-600	ASPIRIN LOW DOSE (ASPIRIN) TABLET, DELAYED RELEASE [L.N.K. INTERNATIONAL, INC.]	16	Current NDC, Legacy NDC, 8 package rows	20240619_2f6ec676-3832-420e-be91-fce83f6586c8.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 35 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Goodys Cool Orange Headache	ACETAMINOPHEN AND ASPIRIN AND CAFFEINE	Medtech Products Inc.	31212c97-9975-427e-bc3d-f7125f30299a	2025-10-23	Warnings	Exact identifier application number: M013
BC Arthritis	ASPIRIN AND CAFFEINE	Medtech Products Inc.	3a85be2d-6548-4de5-8109-60e1ca2bfca3	2025-10-23	Warnings	Exact identifier application number: M013
Goodys Extra Strength	ACETAMINOPHEN, ASPIRIN, AND CAFFEINE	Medtech Products Inc.	d4325b17-23bc-44ac-868d-bb0886853a73	2025-10-23	Warnings	Exact identifier application number: M013
BC	ASPIRIN AND CAFFEINE	Medtech Products Inc.	226173d4-b6d5-4fe6-b24e-1cc5d1b31c88	2025-10-23	Warnings	Exact identifier application number: M013
BC MAX	ASPIRIN, ACETAMINOPHEN, CAFFEINE	Medtech Products Inc.	1e2a07ab-23e6-49b4-a676-212dc6880f14	2025-10-23	Warnings	Exact identifier application number: M013
Ecotrin Regular Strength	ASPIRIN	Medtech Products Inc.	36cb530b-25b2-4f62-a25d-aa04360815a8	2025-10-23	Warnings	Exact identifier application number: M013
Childrens Pain and Fever	ACETAMINOPHEN	TOPCO ASSOCIATES LLC	bbc367cc-6c79-498e-8fca-1347e6ea1a8c	2025-10-22	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	Rugby Laboratories	b16ed4ef-689c-4df2-ab6c-207aa8b9925d	2025-10-22	Warnings	Exact identifier application number: M013
Tension Headache Relief	ACETAMINOPHEN, CAFFEINE	TIME CAP LABS INC	05364eb4-07a1-a4d9-e063-6294a90a47e5	2025-10-21	Warnings	Exact identifier application number: M013
Acetaminophen, Aspirin, Caffeine	ACETAMINOPHEN, ASPIRIN, CAFFEINE	CVS Pharmacy, Inc.	6deb854f-863e-24ad-e053-2991aa0afb17	2025-10-21	Warnings	Exact identifier application number: M013
BackAid	ACETAMINOPHEN, CAFFEINE	Kobayashi Healthcare International, Inc.	25db6bb5-96b6-4be1-e063-6294a90a2300	2025-10-21	Warnings	Exact identifier application number: M013
M-PAP	ACETAMINOPHEN	Method Pharmaceuticals, LLC	1539dc44-15a0-153b-e063-6294a90a9d45	2025-10-21	Warnings	Exact identifier application number: M013
M-PAP	ACETAMINOPHEN	Method Pharmaceuticals, LLC	3d1bb61c-15db-4eba-aba9-cfbcbc7b30e0	2025-10-21	Warnings	Exact identifier application number: M013
Walgreens Antacid Pain Relief Extra Strength	ASPIRIN, CITRIC ACID, SODIUM BICARBONATE	Walgreens	b60df498-07db-500b-e053-2a95a90aff6a	2025-10-17	Warnings	Exact identifier application number: M013
Equate Effervescent Antacid and Pain Relief	ASPIRIN, CITRIC ACID, SODIUM BICARBONATE	Walmart	6271b34b-55a0-40a8-e053-2a91aa0acb22	2025-10-17	Warnings, Adverse reactions	Exact identifier application number: M013
Xesso Neo	BENZOCAINE	PREMIUM NATURAL COSMETICS INC	163f32cd-4e51-950a-e063-6394a90a4816	2025-10-17	Warnings	Exact identifier application number: M013
Menstrual Complete Maximum Strength	ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE	CHAIN DRUG MARKETING ASSOCIATION INC	913d8bdb-7644-464c-b9a6-55387ff12059	2025-10-17	Warnings	Exact identifier application number: M013
Alka-Seltzer Hangover Relief	ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE	Bayer HealthCare LLC.	dc235b06-999e-221d-e053-2a95a90a0ce1	2025-10-16	Warnings	Exact identifier application number: M013
Aspirin 81mg	ASPIRIN ENTERIC COATED TABLETS 81MG	VITANE PHARMACEUTICALS, INC	41386de5-5857-efab-e063-6294a90afd9c	2025-10-15	Warnings	Exact identifier application number: M013
Aspirin 81mg	ASPIRIN ENTERIC COATED TABLETS 81MG	VITANE PHARMACEUTICALS, INC	4138d4c0-baa5-1f20-e063-6394a90a788f	2025-10-15	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	2f6ec676-3832-420e-be91-fce83f6586c8	17
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	2f6ec676-3832-420e-be91-fce83f6586c8	17
308416	ASA 81 MG Delayed Release Oral Tablet	SY	2f6ec676-3832-420e-be91-fce83f6586c8	17
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	2f6ec676-3832-420e-be91-fce83f6586c8	17
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	95c34d67-3a72-49d4-89aa-7186ac58c0dc	2
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	95c34d67-3a72-49d4-89aa-7186ac58c0dc	2
308416	ASA 81 MG Delayed Release Oral Tablet	SY	95c34d67-3a72-49d4-89aa-7186ac58c0dc	2
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	95c34d67-3a72-49d4-89aa-7186ac58c0dc	2
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	52435568-ccc6-4823-8abb-9b60a9a9216b	1
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	52435568-ccc6-4823-8abb-9b60a9a9216b	1
308416	ASA 81 MG Delayed Release Oral Tablet	SY	52435568-ccc6-4823-8abb-9b60a9a9216b	1
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	52435568-ccc6-4823-8abb-9b60a9a9216b	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50844-600-01	50844060001	1 in 1 BOX					Historical
50844-600-14	50844060014	500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (50844-600-14)	2011-05-01		No	No	Current
50844-600-17	50844060017	300 in 1 BOTTLE, PLASTIC					Historical
50844-600-32	50844060032	1 BOTTLE, PLASTIC in 1 BOX (50844-600-32) / 120 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC	2011-05-01	0000-00-00	No	No	Current
50844-600-95	50844060095	300 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (50844-600-95)	2011-05-01		No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Quality Plus 44-600A	L.N.K. International, Inc. \| LNK International, Inc.	2026-06-19	HUMAN OTC DRUG LABEL	19
Aspirin - NuCare Pharmaceuticals,Inc.	NuCare Pharmaceuticals,Inc.	2019-10-29	HUMAN OTC DRUG LABEL	2
Quality Plus 44-600A	Bryant Ranch Prepack	2018-09-07	HUMAN OTC DRUG LABEL	1
Quality Plus 44-600A	Cambridge Therapeutics Technologies, LLC	2017-06-15	HUMAN OTC DRUG LABEL	1
Adult Low Dose Enteric Coated Aspirin - TYA Pharmaceuticals	TYA Pharmaceuticals	2012-08-22	HUMAN OTC DRUG LABEL	2